{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:25:06Z","timestamp":1783398306919,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05352-z","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T03:24:19Z","timestamp":1686281059000},"page":"1675-1684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Incident psoriasis under treatment with tumor necrosis factor-\u03b1 inhibitors in juvenile idiopathic arthritis patients\u2014analysis of the BiKeR registry"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7323-6846","authenticated-orcid":false,"given":"Angela","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-8710","authenticated-orcid":false,"given":"Ariane","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-6598","authenticated-orcid":false,"given":"Jasmin B.","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-3142","authenticated-orcid":false,"given":"Frank","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Onken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normi","family":"Brueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fasshauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5656-9165","authenticated-orcid":false,"given":"Toni","family":"Hospach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-9136","authenticated-orcid":false,"given":"Markus","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1946-3916","authenticated-orcid":false,"given":"Dirk","family":"Foell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-7832","authenticated-orcid":false,"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"5352_CR1","unstructured":"Thatayatikom A, Modica R, De Leucio A. Juvenile idiopathic arthritis. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554605\/"},{"key":"5352_CR2","unstructured":"Radbruch A (2023) Die Kinder-KD DRFZ. https:\/\/www.drfz.de\/ueber-uns\/patienteninformationen\/studien-in-kinder-und-jugendrheumatologie\/die-kerndokumentation-rheumakranker-kinder-und-jugendlicher\/. Accessed 06 June 2023"},{"key":"5352_CR3","first-page":"869","volume":"29","author":"R Burgos-Vargas","year":"2002","unstructured":"Burgos-Vargas R, Rudwaleit M, Sieper J (2002) The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 29:869\u2013874","journal-title":"J Rheumatol"},{"key":"5352_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002520","volume":"8","author":"LJ Montag","year":"2022","unstructured":"Montag LJ et al (2022) Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study. RMD Open 8:e002520","journal-title":"RMD Open"},{"key":"5352_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","volume":"162","author":"M Augustin","year":"2010","unstructured":"Augustin M et al (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162:633\u2013636","journal-title":"Br J Dermatol"},{"key":"5352_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","volume":"17","author":"IMGJ Bronckers","year":"2015","unstructured":"Bronckers IMGJ, Paller AS, van Geel MJ, van de Kerkhof PCM, Seyger MMB (2015) Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs 17:373\u2013384","journal-title":"Paediatr Drugs"},{"key":"5352_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/09546634.2018.1476653","volume":"30","author":"T Kara","year":"2019","unstructured":"Kara T, Topkarc\u0131 Z, Y\u0131lmaz S, Akaltun \u0130, Erdo\u011fan B (2019) Pediatric patients with psoriasis and psychiatric disorders: premorbidity and comorbidity in a case-control study. J Dermatol Treat 30:129\u2013134","journal-title":"J Dermatol Treat"},{"key":"5352_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pde.15185","volume":"40","author":"E Strouphauer","year":"2023","unstructured":"Strouphauer E, Stolar A, Tollefson M (2023) Manifestation of anxiety and depression among pediatric patients with psoriasis: a review. Pediatr Dermatol 40:11\u201318","journal-title":"Pediatr Dermatol"},{"key":"5352_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2340\/00015555-1193","volume":"92","author":"E Hrehor\u00f3w","year":"2012","unstructured":"Hrehor\u00f3w E, Salomon J, Matusiak L, Reich A, Szepietowski JC (2012) Patients with psoriasis feel stigmatized. Acta Derm Venereol 92:67\u201372","journal-title":"Acta Derm Venereol"},{"key":"5352_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/acr.24100","volume":"73","author":"LH Buckley","year":"2021","unstructured":"Buckley LH, Xiao R, Perman MJ, Grossman AB, Weiss PF (2021) Psoriasis associated with tumor necrosis factor inhibitors in children with inflammatory diseases. Arthritis Care Res 73:215\u2013220","journal-title":"Arthritis Care Res"},{"key":"5352_CR11","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945\u20131960","journal-title":"JAMA"},{"key":"5352_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4274\/balkanmedj.2017.0111","volume":"34","author":"K Barut","year":"2017","unstructured":"Barut K, Adrovic A, \u015eahin S, Kasap\u00e7opur \u00d6 (2017) Juvenile idiopathic arthritis. Balk Med J 34:90\u2013101","journal-title":"Balk Med J"},{"key":"5352_CR13","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"D-I Jang","year":"2021","unstructured":"Jang D-I et al (2021) The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current tnf-\u03b1 inhibitors in therapeutics. Int J Mol Sci 22:2719","journal-title":"Int J Mol Sci"},{"key":"5352_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/ijms19030768","volume":"19","author":"H Lim","year":"2018","unstructured":"Lim H et al (2018) Structural biology of the TNF\u03b1 antagonists used in the treatment of rheumatoid arthritis. Int J Mol Sci 19:768","journal-title":"Int J Mol Sci"},{"key":"5352_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L et al (2020) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 79:700\u2013712","journal-title":"Ann Rheum Dis"},{"key":"5352_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jbspin.2007.06.011","volume":"75","author":"D Wendling","year":"2008","unstructured":"Wendling D et al (2008) Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy. Joint Bone Spine 75:315\u2013318","journal-title":"Joint Bone Spine"},{"key":"5352_CR17","first-page":"546","volume":"8","author":"LH Kircik","year":"2009","unstructured":"Kircik LH, Del Rosso JQ (2009) Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol JDD 8:546\u2013559","journal-title":"J Drugs Dermatol JDD"},{"key":"5352_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semarthrit.2019.07.004","volume":"50","author":"L Baganz","year":"2020","unstructured":"Baganz L et al (2020) Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis. Semin Arthritis Rheum 50:36\u201341","journal-title":"Semin Arthritis Rheum"},{"key":"5352_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/annrheumdis-2021-221694","volume":"81","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Sullivan E, Son MB, Beukelman T (2022) Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA. Ann Rheum Dis 81:662\u2013665","journal-title":"Ann Rheum Dis"},{"key":"5352_CR20","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G et al (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63:1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"5352_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"G Horneff","year":"2009","unstructured":"Horneff G et al (2009) Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 68:519\u2013525","journal-title":"Ann Rheum Dis"},{"key":"5352_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/rheumatology\/kev414","volume":"55","author":"A Consolaro","year":"2016","unstructured":"Consolaro A, Ravelli A (2016) Defining criteria for disease activity states in juvenile idiopathic arthritis. Rheumatol Oxf Engl 55:595\u2013596","journal-title":"Rheumatol Oxf Engl"},{"key":"5352_CR23","unstructured":"Kirkwood BR, Sterne JA (2003) Medical Statistics, 2nd edn. Wiley-Blackwell, Hoboken (New Jersey, USA), pp 237\u2013239, pp 310\u2013311, pp 240\u2013243"},{"key":"5352_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40272-021-00440-8","volume":"23","author":"N Rosenwasser","year":"2021","unstructured":"Rosenwasser N, Lee D, Sidbury R, Zhao Y (2021) Paradoxical psoriasis in children receiving anti-TNF\u03b1 treatment for inflammatory\/autoimmune disease. Paediatr Drugs 23:131\u2013141","journal-title":"Paediatr Drugs"},{"key":"5352_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005028.pub3","author":"AR Mason","year":"2013","unstructured":"Mason AR, Mason J, Cork M, Dooley G, Hancock H (2013) Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005028.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5352_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40261-021-01072-z","volume":"41","author":"SY Tan","year":"2021","unstructured":"Tan SY, Chandran NS, Choi EC-E (2021) Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety. Addiction and Withdrawal Clin Drug Investig 41:835\u2013842","journal-title":"Addiction and Withdrawal Clin Drug Investig"},{"key":"5352_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000422371","volume":"21","author":"CM Mills","year":"1993","unstructured":"Mills CM, Marks R (1993) Side effects of topical glucocorticoids. Curr Probl Dermatol 21:122\u2013131","journal-title":"Curr Probl Dermatol"},{"key":"5352_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","volume":"9","author":"U Wollina","year":"2008","unstructured":"Wollina U et al (2008) Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 9:1\u201314","journal-title":"Am J Clin Dermatol"},{"key":"5352_CR29","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","volume":"9","author":"A Mylonas","year":"2018","unstructured":"Mylonas A, Conrad C (2018) Psoriasis: classical vs. paradoxical. The Yin-Yang of TNF and type I interferon. Front Immunol 9:2746","journal-title":"Front Immunol"},{"key":"5352_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","volume":"9","author":"C Conrad","year":"2018","unstructured":"Conrad C et al (2018) TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nat Commun 9:25","journal-title":"Nat Commun"},{"key":"5352_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/pde.14712","volume":"38","author":"BM Cyrenne","year":"2021","unstructured":"Cyrenne BM, Parpia AS, Sibbald C (2021) Paradoxical psoriasis in pediatric patients: a systematic review. Pediatr Dermatol 38:1086\u20131093","journal-title":"Pediatr Dermatol"},{"key":"5352_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pde.13859","volume":"36","author":"D Groth","year":"2019","unstructured":"Groth D et al (2019) Tumor necrosis factor-\u03b1 inhibitor-induced psoriasis in juvenile idiopathic arthritis patients. Pediatr Dermatol 36:613\u2013617","journal-title":"Pediatr Dermatol"},{"key":"5352_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-017-8642-3","volume":"56","author":"M Cattalini","year":"2019","unstructured":"Cattalini M, Soliani M, Caparello MC, Cimaz R (2019) sex differences in pediatric rheumatology. Clin Rev Allergy Immunol 56:293\u2013307","journal-title":"Clin Rev Allergy Immunol"},{"key":"5352_CR34","first-page":"54","volume":"28","author":"A Kouris","year":"2017","unstructured":"Kouris A, Platsidaki E, Kouskoukis C, Christodoulou C (2017) Psychological parameters of psoriasis. Psychiatr Psychiatr 28:54\u201359","journal-title":"Psychiatr Psychiatr"},{"key":"5352_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1525-1470.2011.01489.x","volume":"28","author":"MEA De Jager","year":"2011","unstructured":"De Jager MEA, De Jong EMGJ, Evers AWM, Van De Kerkhof PCM, Seyger MMB (2011) The burden of childhood psoriasis. Pediatr Dermatol 28:736\u2013737","journal-title":"Pediatr Dermatol"},{"key":"5352_CR36","first-page":"224","volume":"32","author":"F Benhadou","year":"2011","unstructured":"Benhadou F, Willaert F (2011) Psoriasis: a chronic skin disease. Rev Med Brux 32:224\u2013229","journal-title":"Rev Med Brux"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05352-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05352-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05352-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T18:02:54Z","timestamp":1689357774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05352-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["5352"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05352-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}